Catalent Acquires Australia’s Pharmapak Technologies

April 3, 2015
Pharmaceutical Technology Editors

Catalent acquires Pharmapak Technologies, a pharmaceutical packaging company based in New South Wales, Australia.

 

Catalent announced on March 30, 2014 that it acquired Pharmapak Technologies, a pharmaceutical packaging business based out of New South Wales, Australia. Catalent currently operates a facility in Braeside, Victoria, where it produces oral-dose products to supply throughout Asia Pacific. The acquisition will give Catalent regional packaging options for its local production.

“This acquisition complements our industry-leading oral-dosage form development and manufacturing capabilities with a broader range of packaging options, from bulk supply to finished packs,” said Mark Bisset, president of Catalent Asia Pacific, in a press release. “Catalent has made substantial recent investments in Asia Pacific with a new facility in China, and last year we celebrated our 40th year in Japan with a new laboratory and the build-out of more manufacturing capacity. This latest investment is in response to strong, local market demand for both pharmaceutical, over-the-counter (OTC), and Complementary Medicine products.”

Source: Catalent